Download PDF
Dtsch Med Wochenschr 2007; 132(25/26): 1399-1403
DOI: 10.1055/s-2007-982043
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Infektiologie und Tropenmedizin 2007

Infectiology and tropical medicine 2007M. Löbermann1 , E. C. Reisinger1
  • 1Abteilung für Tropenmedizin und Infektionskrankheiten, Klinik für Innere Medizin, Universitätsklinik Rostock
Further Information

Publication History

eingereicht: 24.5.2007

akzeptiert: 24.5.2007

Publication Date:
15 June 2007 (online)

Also available at
    Permissions and Reprints

Was ist neu?

  • Neue Erreger: Klebsiellen- und E-coli-Stämme

  • Reisediarrhoe: Antibiotika im Test

  • Neue Antibiotika: Daptomycin, Tigecyclin, Dalbavancin, Telavancin

  • Antimykotika: Micafungin, zyklische b-Aminosäuren

  • Tuberkulose: Problematische Resistenzen. Lymphozyten-Stimulations-Test

  • HIV und AIDS: Prävention stagniert. Therapeutische Innovationen

  • Impfungen: Neue Empfehlungen, neue Entwicklungen

  • Malaria tropica: Artesunate bei komplizierter Malaria. Chikungunya-Fieber

Literatur

  • 1 Anonymus. Newer approaches to HIV prevention.  Lancet. 2007;  369 615
    Google Scholar
  • 2 Bailey R C, Moses S, Parker C B. et al . Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.  Lancet. 2007;  369 643-656
    Google Scholar
  • 3 Blumenthal R, Dimitrov D S. Targeting the Sticky Fingers of HIV-1.  Cell. 2007;  129 243-345
    Google Scholar
  • 4 Brooks J T, Ochieng J B, Kumar L. et al . Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997 - 2003.  Clin Infect Dis. 2006;  43 393-401)
    Google Scholar
  • 5 CDC. Pertussis-United States, 2001 - 2003.  MMWR Morb Mortal Wkly Rep. 2005;  54 1283-1286
    Google Scholar
  • 6 Chen A Y, Zervos M J, Vazquez J A. Dalbavancin: a novel antimicrobial.  Int J Clin Pract. 2007;  61 853-863
    Google Scholar
  • 7 Chretien J P, Anyamba A, Bedno S A. et al . Drought-associated chikungunya emergence along coastal East Africa.  Am J Trop Med Hyg. 2007;  76 405-407
    Google Scholar
  • 8 Clotet B, Bellos N, Molina J M. et al . Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials.  Lancet. 2007;  369 1169-1178
    Google Scholar
  • 9 Dewan P K, Grinsdale J, Kawamura L M. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis.  Clin Infect Dis. 2007;  44 69-73
    Google Scholar
  • 10 Friedman L N, Nash E R, Bryant J. et al . High rate of negative results of tuberculin and QuantiFERON tests among individuals with a history of positive skin test results.  Infect Control Hosp Epidemiol. 2006;  27 436-441
    Google Scholar
  • 11 Gray R H, Kigozi G. et al . Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.  Lancet. 2007;  369 657-666
    Google Scholar
  • 12 Greenwald J L, Burstein G R, Pincus J, Branson B. A rapid review of rapid HIV antibody tests.  Curr Infect Dis Rep. 2006;  8 125-131
    Google Scholar
  • 13 Grinsztejn B, Nguyen B Y. et al . Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.  Lancet. 2007;  369 1261-1269
    Google Scholar
  • 14 Hampton T. Marburg vaccine shows promise: offers postexposure protection in monkeys.  Jama. 2006;  295 2346
    Google Scholar
  • 15 Harper D M. et al . Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18l.  Lancet. 2006;  367 1247-1255
    Google Scholar
  • 16 Hasenoehrl A, Galic T. et al . In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast Candida albicans.  Antimicrob Agents Chemother. 2006;  50 3011-3018
    Google Scholar
  • 17 Hasin T, Davidovitch N, Cohen R. et al . Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever.  N Engl J Med. 2006;  355 148-155
    Google Scholar
  • 18 Hicks C B, Cahn P, Cooper D A. et al . Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials.  Lancet. 2006;  368 466-475
    Google Scholar
  • 19 Hill D R, Ford L, Lalloo D G. Oral cholera vaccines: use in clinical practice.  Lancet Infect Dis. 2006;  6 361-373
    Google Scholar
  • 20 Hoffmann H, Loytved G, Bodmer T. Interferon-γ-Release-Assays in der Tuberkulosediagnostik.  Internist (Berl). 2007;  48 497-506
    Google Scholar
  • 21 Högenauer C, Hammer F H, Krejs G J, Reisinger E C. Mechanisms and Management of Antibiotic-Associated Diarrhea.  Clin Infect Dis. 1998;  27 702-710
    Google Scholar
  • 22 Högenauer C, Langner C, Beubler E. et al . Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis.  N Engl J Med. 2006;  355 2418-2426
    Google Scholar
  • 23 Hornberger J, Robertus K. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  Ann Intern Med. 2006;  145 317-325
    Google Scholar
  • 24 Kabir S. Cholera vaccines.  Lancet Infect Dis. 2007;  7 176-178
    Google Scholar
  • 25 Klug S J, Hukelmann M, Hollwitz B. et al . Prevalence of human papillomavirus types in women screened by cytology in Germany.  J Med Virol. 2007;  79 616-525
    Google Scholar
  • 26 Kobashi Y, Obase Y. et al . Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.  Clin Infect Dis. 2006;  43 1540-1546
    Google Scholar
  • 27 Krause R, Schwab E, Bachhiesl D, Wenisch C, Krejs G J, Reisinger E C. Role of Candida in Antibiotic-Associated Diarrhea.  J Infect Dis. 2001;  184 1065-1069
    Google Scholar
  • 28 MacArthur R D. Darunavir: promising initial results.  Lancet. 2007;  369 1143-1144
    Google Scholar
  • 29 Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.  Ann Intern Med. 2007;  146 340-345
    Google Scholar
  • 30 Munch J, Standker L, Adermann K. et al . Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide.  Cell. 2007;  129 263-275
    Google Scholar
  • 31 Nataro J P, Mai V, Johnson J. et al . Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut.  Clin Infect Dis. 2006;  43 402-407
    Google Scholar
  • 32 Oxman M N, Levin M J, Johnson G R. et al . A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  N Engl J Med. 2005;  352 2271-2284
    Google Scholar
  • 33 Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis?.  Clin Infect Dis. 2007;  44 74-77
    Google Scholar
  • 34 Raad I, Hanna H, Jiang Y. et al . Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm.  Antimicrob Agents Chemother. 2007;  51 1656-1660
    Google Scholar
  • 35 SurvStat. 2007. (Accessed 30.04.2007, 2007, at http://www3.rki.de/SurvStat.)
    Google Scholar
  • 36 Reisinger E C, Burchard G D. Neues in der Infektiologie und Tropenmedizin.  Dtsch Med Wochenschr. 2006;  131 1474-1478
    Google Scholar
  • 37 RKI . Zum Welttuberkulosetag 2007. Tuberkulose irgendwo heißt Tuberkulose überall!.  Epidemiol Bul. 2007;  11 87-93
    Google Scholar
  • 38 Rothberg M B, Virapongse A, Smith K J. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.  Clin Infect Dis. 2007;  44 1280-1288
    Google Scholar
  • 39 Schmiedeskamp M R, Kockler D R. Human papillomavirus vaccines.  Ann Pharmacother. 2006;  40 1344-1352
    Google Scholar
  • 40 Seedat J, Zick G, Klare I, Konstabel C, Weiler N, Sahly H. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.  Antimicrob Agents Chemother. 2006;  50 4217-4219
    Google Scholar
  • 41 Sidley P. South Africa acts to curb spread of lethal strain of TB.  Bmj. 2006;  333 825
    Google Scholar
  • 42 Steiner T S, Samie A, Guerrant R L. Infectious diarrhea: new pathogens and new challenges in developed and developing areas.  Clin Infect Dis. 2006;  43 408-410
    Google Scholar
  • 43 STIKO . Empfehlung der Ständigen Impfkommission (STIKO) am Robert Koch-Institut zur Pertussis-Schutzimpfung.  Epidemiol Bull. 2006;  3 21-23
    Google Scholar
  • 44 STIKO . Neuerungen in den aktuellen Empfehlungen der Ständigen Impfkommission (STIKO) am RKI vom Juli 2006.  Epidemiol Bull. 2006;  32 271-276
    Google Scholar
  • 45 STIKO . Impfung gegen humane Papillomaviren (HPV) für Mädchen von 12 bis 17 Jahren - Empfehlung und Begründung.  Epidemiol Bull. 2007;  12 97-103
    Google Scholar
  • 46 Taylor D N, Bourgeois A L. et al . A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers’ diarrhea.  Am J Trop Med Hyg. 2006;  74 1060-1066
    Google Scholar
  • 47 Teo J W, Thayalan P, Beer D. et al . Peptide deformylase inhibitors as potent antimycobacterial agents.  Antimicrob Agents Chemother. 2006;  50 3665-3673
    Google Scholar
  • 48 Tornesello M L. et al . Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy.  Infect Agent Cancer. 2007;  2 1
    Google Scholar
  • 49 Treanor J J, Schiff G M. et al . Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.  Jama. 2007;  297 1577-1582
    Google Scholar
  • 50 Tribble D R, Sanders J W, Pang L W. et al . Traveler’s diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.  Clin Infect Dis. 2007;  44 338-346
    Google Scholar
  • 51 UNAIDS .Report on the global AIDS epidemic 2006. Geneva: UNAIDS 2006
    Google Scholar
  • 52 WHO .Guidelines for the treatment of severe malaria. (Accessed 2007 - 05 - 11, 2007, at www.who.int/malaria/docs/TreatmentGuidelines2006.pdf ) 2006
    Google Scholar
  • 53 Xu Q A, Yu F, Fan M W. et al . Immunogenicity and persistence of a targeted anti-caries DNA vaccine.  J Dent Res. 2006;  85 91591-91598
    Google Scholar
  • 54 Xu Q A, Yu F, Fan M W. et al . Protective efficacy of a targeted anti-caries DNA plasmid against cariogenic bacteria infections.  Vaccine. 2007;  25 1191-1195
    Google Scholar
  • 55 Stryjewski M E, Chu V H, O’Riordan W D. et al . Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 Study.  Antimicrob Agents Chemother. 2006;  50(3) 862-867
    Google Scholar
  • 56 Kohli M, Ferko N, Martin A. et al . Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK.  Br J Cancer. 2007;  96(1) 143-150
    Google Scholar
  • 57 Dondorp A, Nosten F, Stepniewska K. et al . Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.  Lancet. 2005;  366(9487) 717-725
    Google Scholar

Prof. Dr. med. Emil C. Reisinger

Abteilung für Tropenmedizin und Infektionskrankheiten, Universitätsklinik Rostock

Ernst Heydemann Str. 6

18057 Rostock

Phone: 0381/4947511

Fax: 0381/4947509

Email: emil.reisinger@medizin.uni-rostock.de

      >